Livalo Tablet, Film Coated
Product Images NDC 66869-404
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Livalo (NDC 66869-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kowa Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Liv01 0008 02
The text provided refers to a comparison of the efficacy of different treatments on percentage change in a certain measurement. The treatments compared are Ataryastatin, Aorvastatin, Simvastatin, Pravastatin, and Livalo, at different doses. The comparison was made in different studies identified by codes such as NK-104-301, NK-104-304, and NK-104-308. The results are shown in a chart where the treatments are organized from the one with the most efficacy to the one with the least. The chart also shows a graph that displays the degree of efficacy in each treatment. However, more context about the measurement and specific variables is needed to understand the full scope of the analysis.*
Liv01 0008 03
This is a prescription drug called "Pitavastatin" manufactured by Kowa Pharmaceuticals. Each tablet contains 1.045 mg of Pitavastatin and is used to treat high cholesterol. The drug should be stored in a tightly sealed, light-resistant, and child-resistant container at controlled room temperature. The dosage information, as well as the prescribing information, is printed on the label. The drug is available in a pack containing 90 tablets.*
Liv01 0008 04
This text is prescribing information for a medication called "Feghoc o dapan" (equivalent to Itavastatin) with each tablet containing 2.09 mg. The manufacturer of the medication is Kowa Company Ltd. and the product code is 66869-204-90. The medication should be stored at a temperature of 25°C (17°F) with permissible excursions from 15°C-30°C (S9°F-86°F). The prescription can only be filled by a licensed pharmacy and should be dispensed in a child-resistant container. The information is from Japan.*
Liv01 0008 05
Dosage and use information for a medication called Livalo. The medication comes in a package containing 90 tablets and each tablet contains 418 mg of a substance called piavastatin, which is used as a treatment for high cholesterol. The package is marked with an NDC number, which identifies the medication to the FDA. The medication should be stored at room temperature between 15-30°C and protected from moisture and light. It is manufactured by Kowa Pharmaceuticals and dispensed in the US.*
Liv01 0008 06
This is a product description for a free sample of Livalo tablets containing 7 tablets with an active ingredient of pitavastatin calcium. It is for professional use only and should be taken as directed by a physician. The tablets come in foil packaging, which can be opened by pushing the tablet through the foil seal. The medication should be stored at a temperature of 15°C-30°C (59°F-86°F) and kept out of reach of children. For more information about this product, visit www.LivaloRX.com.*
Liv01 0008 07
This is a description of a free sample of Livalo (pitavastatin) tablets with 7 tablets in a pack. The active ingredient is pitavastatin calcium and each tablet contains 4.18 mg equivalent to pitavastatin 4 mg. The tablets come in a foil seal and should be removed by pushing from the front. It is intended for professional sample use only and should not be sold. The medication should be stored at room temperature, between 25°C (77°F) and 30°C (86°F), and kept out of the reach of children. For more information, visit www.LivaloRX.com.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.